找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Haemostasis in Spine Surgery; Marek Szpalski,Richard B. Weiskopf,Max Aebi Conference proceedings 2005 Springer-Verlag Berlin Heidelberg 20

[復制鏈接]
樓主: ARRAY
31#
發(fā)表于 2025-3-26 23:38:26 | 只看該作者
32#
發(fā)表于 2025-3-27 04:27:45 | 只看該作者
ing in spine surgery. This publication fills a gap in the spinal literature and provides invaluable data for all those confronted with blood loss during surgical procedures on the spine.978-3-540-27394-3
33#
發(fā)表于 2025-3-27 08:19:38 | 只看該作者
34#
發(fā)表于 2025-3-27 10:06:24 | 只看該作者
https://doi.org/10.1057/9781137283382demonstrate the highest mean levels of blood loss. Blood loss is also shown to be progressively greater with increasing numbers of vertebral levels incorporated into the fusion, with posterior fusions compared to anterior fusions, and in those patients having both anterior and posterior fusions.
35#
發(fā)表于 2025-3-27 16:39:05 | 只看該作者
36#
發(fā)表于 2025-3-27 20:14:01 | 只看該作者
Phyllis A. Katz Ph.D.,Margaret Katzhese haemostats have been used in neurosurgical intraspinal procedures for more than 30 years; however, new application forms like Surgicel fibrillar and Surgifoam powder imply different handling options, which are discussed in this paper.
37#
發(fā)表于 2025-3-28 00:12:46 | 只看該作者
38#
發(fā)表于 2025-3-28 02:41:22 | 只看該作者
Aprotinin and major orthopedic surgerys and pulmonary embolism was observed. The only major side effect could be the potential occurrence of an anaphylactoid reaction. Prophylactic administration of aprotinin should be considered in extensive spine surgery and in high-risk major orthopedic operations. The decision to use aprotinin should be guided by a risk/ benefit analysis.
39#
發(fā)表于 2025-3-28 08:48:34 | 只看該作者
The use of local agents: surgicel and surgifoamhese haemostats have been used in neurosurgical intraspinal procedures for more than 30 years; however, new application forms like Surgicel fibrillar and Surgifoam powder imply different handling options, which are discussed in this paper.
40#
發(fā)表于 2025-3-28 13:06:59 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 13:26
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
吉水县| 昭觉县| 永善县| 台江县| 钦州市| 乡宁县| 卫辉市| 旬阳县| 麻阳| 南宫市| 肇东市| 江西省| 衡阳县| 庆云县| 彭州市| 江安县| 凭祥市| 社旗县| 太和县| 临漳县| 沅江市| 台中县| 弥渡县| 焦作市| 昌吉市| 开封县| 绥江县| 库车县| 哈尔滨市| 明溪县| 麻江县| 甘南县| 内黄县| 包头市| 淮南市| 都昌县| 佛山市| 阳城县| 霍山县| 铜梁县| 永寿县|